Pathogenic variants in GBX2 cause craniofacial microsomia

Run Yang, Wenqing Han, Liang Wang, Xin Chen, Ying Chen, Bowen Li, Maoxiang Qian, Dong Liu, Tianyu Zhang, Jing MaGenes 2025 · DOI

TL;DR

Researchers have identified pathogenic variants in the GBX2 gene as a cause of craniofacial microsomia (CFM), a congenital malformation. By combining human genetic studies with zebrafish models, they demonstrate that these GBX2 variants lead to impaired cranial neural crest cell proliferation, offering a new understanding of CFM's genetic underpinnings.

What Problem Does This Paper Address?

Craniofacial microsomia (CFM) is a group of birth defects affecting the development of the face and skull, impacting an estimated 1 in 3600 to 5600 live births. While genetics plays a significant role, the specific genetic causes for a substantial portion of CFM cases remain unknown. Previous studies have identified several genes involved, but a comprehensive understanding of all contributing factors is still lacking. This paper aims to identify novel genetic causes of CFM, specifically investigating the GBX2 gene, which was previously linked to CFM through a genome-wide association study but had no direct pathogenic variants identified.

Methods

The researchers employed a multi-pronged approach:

  • Whole-Exome Sequencing (WES): They analyzed WES data from 201 families with CFM to identify rare genetic variants.
  • Segregation Analysis: They confirmed that identified variants co-segregated with the CFM phenotype within affected families.
  • In Vitro Functional Assays:
    • Conservation Analysis: Assessed the evolutionary conservation of affected amino acids to infer potential functional importance.
  • Pathogenicity Prediction: Used computational tools to predict the likelihood of variants causing disease.
  • Structural Modeling: Explored how the amino acid substitutions might affect protein structure and folding.
  • Luciferase Reporter Assays: Investigated the impact of the variants on GBX2's ability to regulate the transcription of downstream target genes, specifically the EEF1A1 gene.
  • Zebrafish Model:
    • CRISPR Interference (CRISPRi): Knocked down gbx2 expression in zebrafish embryos to mimic the loss-of-function effect.
  • Phenotypic Analysis: Assessed the developmental impact of gbx2 knockdown on craniofacial structures, particularly pharyngeal arch cartilage.
  • Rescue Experiments: Injected wild-type or mutant human GBX2 mRNA into gbx2-deficient zebrafish to determine if the variants could restore normal development.
  • Cell Proliferation Assays (BrdU labeling): Quantified the proliferation of cranial neural crest cells (CNCCs) in control and gbx2-deficient embryos.

Datasets

  • Human WES Data: Data from a cohort of 201 families clinically diagnosed with CFM.
  • Zebrafish Embryogenesis Spatiotemporal Transcriptomic Atlas (ZESTA): Used for analyzing gbx2 expression patterns.
  • Single-cell Transcriptome Data (Zebrafish): Used to characterize cell types and gbx2 expression in the pharyngeal arch lineage.

Key Insights and Ideas

  • GBX2 as a Novel CFM Gene: The study definitively links pathogenic variants in GBX2 to craniofacial microsomia, expanding the known genetic landscape of this condition.
  • Loss-of-Function Mechanism: The identified variants appear to cause CFM through a loss-of-function mechanism, impairing GBX2's ability to activate gene transcription.
  • CNCC Proliferation is Crucial: The research highlights the critical role of GBX2 in the proliferation of cranial neural crest cells, which are essential building blocks for craniofacial development. Disruption of this process directly leads to craniofacial malformations.
  • Zebrafish as a Powerful Model: The zebrafish model proved invaluable for functionally validating the human genetic findings, allowing for in vivo assessment of gene function and the impact of specific variants.
  • Functional Divergence of Variants: The study suggests that the p.Ala4Val variant may have a more severe impact than p.Gln67His, as indicated by its more pronounced failure to rescue phenotypes in the zebrafish model.

Key Results

  • Two rare heterozygous missense variants in GBX2 (c.11C > T [p.Ala4Val] and c.201G > C [p.Gln67His]) were identified in three unrelated CFM families and segregated with the phenotype.
  • Both variants were found to significantly reduce the transcriptional activation of the EEF1A1 gene in HEK293T cells, supporting a loss-of-function mechanism.
  • Knockdown of gbx2 in zebrafish embryos led to hypoplasia of pharyngeal arch cartilages and a reduction in CNCC numbers.
  • Wild-type human GBX2 mRNA could rescue the gbx2 knockdown phenotypes in zebrafish, but the mutant variants (p.Ala4Val and p.Gln67His) could not.
  • BrdU assays showed a marked reduction in proliferating CNCCs in gbx2-deficient embryos, which was rescued by wild-type but not mutant GBX2.
  • The authors estimate that approximately 1.5% of CFM cases may be attributable to GBX2 variants.

Limitations and Future Work

  • Contribution to CFM Prevalence: While the study identifies GBX2 as a cause, further studies with larger cohorts are needed to precisely determine the overall contribution of GBX2 variants to the broader CFM population.
  • Model Discrepancies: The zebrafish model recapitulated some craniofacial features, but discrepancies with human phenotypes suggest the need for improved models.
  • Role in Migration: The study focused on CNCC proliferation, but the role of GBX2 in CNCC migration remains unclear and warrants further investigation.
  • Phenotypic Variability: The observed phenotypic variability among individuals with the same variant suggests the involvement of additional genetic or epigenetic modifiers that need to be identified.
  • Functional Domains: The identified variants are not located within known functional domains of the GBX2 protein, suggesting that their impact might be through subtle structural changes or interactions not yet fully understood.

Summary updated

BibTeX
@inproceedings{yang2025pathogenic,
  author = {Run Yang and Wenqing Han and Liang Wang and Xin Chen and Ying Chen and Bowen Li and Maoxiang Qian and Dong Liu and Tianyu Zhang and Jing Ma},
  title = {{Pathogenic variants in GBX2 cause craniofacial microsomia}},
  booktitle = {Genes},
  year = {2025},
  doi = {10.1016/j.gendis.2025.101814},
}
Figure